CELLTRION-HEALTHCARE
Celltrion Healthcare announced today that the European Commission (EC) has approved Vegzelma™ (CT-P16), a biosimilar bevacizumab referencing EU-approved Avastin® , for the treatment of metastatic breast cancer, non-small cell lung cancer, advanced and/or metastatic renal cell cancer, metastatic carcinoma of the colon or rectum, ovarian cancer and cervical cancer.
“The European Commission’s approval of Vegzelma™ will increase access to treatment for patients living with certain types of cancer at an affordable price,” said Kevin Byoung Seo Choi, Senior Vice President and Head of Marketing Division at Celltrion Healthcare. “With proven similarities in efficacy and safety compared to the reference product Avastin® , Vegzelma™ will be available to treat some of the most commonly diagnosed cancers, which collectively affect hundreds of thousands of European patients each year.”
The EC approval of Vegzelma™ follows the recommendation for marketing authorisation issued by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) in June 2022.
Today’s approval is based on the totality of evidence, including the phase III pivotal trial in patients with metastatic or recurrent non-squamous non-small cell lung cancer. Results showed that, as a first-line treatment, Vegzelma™ is highly similar to the reference product in terms of efficacy, safety and pharmacokinetics.2
Vegzelma™ (CT-P16) is Celltrion’s third oncology biosimilar approved for use in the EU, following the approval of Truxima® (biosimilar rituximab) and Herzuma® (biosimilar trastuzumab). Vegzelma™ was also filed for regulatory approval with the U.S. Food and Drug Administration (FDA) in September 2021. Approval is expected during the third quarter of 2022.
- ENDS -
Notes to Editors:
About Celltrion Healthcare
Celltrion Healthcare is committed to delivering innovative and affordable medications to promote patients’ access to advanced therapies. Its products are manufactured at state-of-the-art mammalian cell culture facilities, designed and built to comply with the US FDA Current Good Manufacturing Practice (cGMP) and the EU GMP guidelines. Celltrion Healthcare endeavours to offer high-quality cost-effective solutions through an extensive global network that spans more than 110 different countries. For more information, please visit: https://www.celltrionhealthcare.com
About Vegzelma™ (CT-P16, biosimilar bevacizumab)
Vegzelma™ is an anti-cancer monoclonal antibody treatment biosimilar to Avastin® (bevacizumab). Vegzelma™ is a recombinant humanised monoclonal antibody which binds to VEGF, the key driver of vasculogenesis and angiogenesis, and thereby inhibits the binding of VEGF to its receptors Flt-1 (VEGFR-1), and kinase insert domain receptor (KDR) (VEGFR-2), on the surface of endothelial cells. Neutralising the biological activity of VEGF regresses the vascularisation of tumours, normalises remaining tumour vasculature, and inhibits the formation of new tumour vasculature, thereby inhibiting tumour growth.3 In the EU, Vegzelma™ is indicated for the treatment of patients with metastatic colorectal cancer, non-small cell lung cancer, metastatic renal cell carcinoma, ovarian cancer, advanced cervical cancer and metastatic breast cancer.
References
1 Avastin is a registered trademark of Genentech Inc.
2 Ohe Y et al., Randomized Phase III Study Comparing the Efficacy and Safety of CT-P16, a New Biosimilar, to Reference Bevacizumab (Avastin) In Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC). Proceedings: American Association for Cancer Research (AACR) Annual Meeting 2022; April 8-13, 2022 New Orleans, Louisiana.
3 European Medicines Agency Summary of Product Characteristics (SmPC), Avastin. Available at https://www.ema.europa.eu/en/documents/product-information/avastin-epar-product-information_en.pdf [Last accessed August 2022].
View source version on businesswire.com: https://www.businesswire.com/news/home/20220817005324/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Games of the Future 2025 Set to Bring the World Together in UAE for the Next Generation of Sport24.10.2025 11:34:00 CEST | Press release
Abu Dhabi, UAE will host the Games of the Future 2025 (GOTF 2025), the groundbreaking global event where phygital sports bring together elite clubs, athletes, and gamers to compete in cutting-edge disciplines that blend real-world athleticism with advanced gaming technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251024640292/en/ Games of The Future Highlights Community, Innovation and Youth Empowerment (Photo: AETOSWire) Taking place from 18-23 December 2025 at ADNEC Centre Abu Dhabi, the tournament is a natural extension of the ‘We the UAE 2031’ vision and the nation’s designation of 2025 as the Year of Community, reinforcing the UAE's role as a global hub for sport, innovation, youth empowerment, and cultural exchange. His Excellency Dr. Ahmad Belhoul Al Falasi, UAE Minister of Sports, affirmed that Abu Dhabi's hosting of the Games of the Future 2025 is a qualitative new step in the country's journey to consolidat
Thales Named Frost & Sullivan’s 2025 Company of the Year in Automated Border Control24.10.2025 08:00:00 CEST | Press release
Thales, a global leader in cybersecurity and identity management, has been recognized by Frost & Sullivan as Company of the Year 2025 in the Automated Border Control (ABC) eGates industry.This award underscores Thales’s ability to consistently innovate, deliver scalable and sustainable solutions, and set new standards for border security and passenger experience worldwide.Frost & Sullivan emphasized Thales’s proven ability to deliver at scale, its close collaboration with ministries of interior and airport operators, and its forward-looking strategy that integrates regulatory compliance, digital identity, and sustainability. As governments and airports face rising passenger volumes, new regulatory requirements such as the European Entry Exit System (EES), and evolving security threats, Thales’s solutions help strike the right balance between strong security and traveller convenience. Frost & Sullivan praised Thales’s end-to-end expertise, customer focus, and ability to design systems t
NTT DOCOMO BUSINESS and NTT Com Asia Launch “APN InterLink” Service in Hong Kong24.10.2025 06:00:00 CEST | Press release
Transforming the Financial Services Industry with IOWN® Infrastructure NTT DOCOMO BUSINESS, Inc. (formerly NTT Communications Corporation, hereafter “NTT DOCOMO BUSINESS”) and its Hong Kong subsidiary, NTT Com Asia, today announced the launch of the “APN InterLink” service in Hong Kong for financial institutions starting November 1, 2025, leveraging All-Photonic Network (APN)*1 technology in support of the IOWN®*2 initiative. Commercially deployed in Hong Kong, one of the leading Asia financial hubs, the new service leverages ultra-low latency photonics-based connectivity to address the evolving digital needs of the financial sector, especially for latency-sensitive trading, algorithmic trading*3, proximity market data access and real-time transaction. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251023916941/en/ NTT APN InterLink Service Looking ahead, NTT DOCOMO BUSINESS and NTT Com Asia plan to expand the deployment of
Hanshow Wins the Technology Vendor of the Year at 2025 RTIH Innovation Awards in London24.10.2025 05:00:00 CEST | Press release
Hanshow, a global leader in digital retail solutions, has been honoured at the 2025 Retail Technology Innovation Hub (RTIH) Innovation Awards, winning the Technology Vendor of the Year title for its pioneering shelf marketing solution. The recognition underscores Hanshow’s commitment to redefining how retailers and brands engage with shoppers through NFC-enabled ESLs that seamlessly connect physical stores with digital engagement. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251023122859/en/ The RTIH Innovation Awards are widely regarded as one of the most influential recognitions in the global retail technology sector. Each year, the awards celebrate organisations driving innovation, digital transformation, and operational excellence in a fast-moving omnichannel world. The 2025 ceremony, held at The HAC in central London, brought together senior retail executives, technology innovators, and thought leaders shaping the fut
DNIB.com Reports Internet Has 378.5 Million Domain Name Registrations at the End of the Third Quarter of 202523.10.2025 23:00:00 CEST | Press release
VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that, according to the latest Domain Name Industry Brief Quarterly Report from DNIB.com, the third quarter of 2025 closed with 378.5 million domain name registrations across all top-level domains (TLDs), an increase of 6.8 million domain name registrations, or 1.8% compared to the second quarter of 2025. Domain name registrations also increased by 16.2 million, or 4.5%, year over year. The .com and .net TLDs had a combined total of 171.9 million domain name registrations in the domain name base at the end of third quarter of 2025, an increase of 1.4 million domain name registrations, or 0.8% compared to the second quarter of 2025. The .com and .net TLDs had a combined increase of 2.4 million domain name registrations, or 1.4%, year over year. As of Sept. 30, 2025, the .com domain name base totaled 159.4 million domain name registrations and the .net do
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom